Valuing Healthcare Biotechnology in Europe: EuropaBio’s perspective


The healthcare biotechnology sector includes bioscience based enterprises, which create and deliver innovative treatments and preventive interventions for the benefit of European patients and European health care systems. The industry makes major investments in innovation in the EU. It is a diverse sector, with more than 2,000 companies in Europe ranging from large multinationals to medium-sized as well as much smaller enterprises. Learn more about the healthcare biotechnology industry in Europe.